Le Lézard
Classified in: Health
Subjects: PER, MAT

CBx Sciences Welcomes Dr. Ben Cowin to Team


DENVER, April 17, 2018 /PRNewswire/ -- CBx Sciences today announced that Dr. Ben Cowin DC, MS, ATC, CAFS has joined its team to consult on the development of unique cannabinoid products designed to support the needs of athletes. Dr. Cowin will also serve as a Brand Ambassador, educating stakeholders about the vast potential benefits of cannabinoid therapeutics.

Dr. Cowin has more than 20 years experience in sports medicine working with professional athletes competing at the highest levels. His experience includes a multitude of arenas such as Major League Baseball, National Football League, Ultimate Fighting Championships, multiple Olympic teams and many others.

Dr. Cowin will be working with CBx Sciences Chief Scientist Noel Palmer, Ph.D. to create new product formulations that meet the unique needs of athletes.

"It's clear that CBD and other cannabinoids can play an important role in health, wellness and human performance," said Dr. Cowin. "Following the recent announcement by the World Anti-Doping Agency that CBD is no longer a banned substance, more and more athletes at all levels are beginning to understand the potential of these natural approaches. With so many different types of hemp and cannabis products, it's essential that users have access to products they can trust, backed by analytical testing for purity and safety. I'm pleased to be working with the skilled team at CBx Sciences to develop this next generation of cannabinoid therapeutics precisely formulated for the athletic community."

"With two decades of experience as a national expert in peak performance, Dr. Cowin has worked with countless professional athletes," said Nicole Smith, CEO, CBx Sciences. "As more amateur and professional athletes, as well as everyday people, begin to understand the many potential benefits of cannabinoid therapeutics, there is an increasing demand for thoughtfully formulated, highly effective products. We are delighted to welcome Dr. Cowin to our team and look forward to working with him to develop new ways of caring for both elite athletes and the rest of us."

Stay tuned for the updates regarding the availability of new CBx Sciences products formulated in partnership with Dr. Cowin over the coming months. Find current CBx Sciences products by visiting the store locator at CBxSciences.com.

About CBx Sciences:
CBx Sciences is an international botanical technology company. Founded by a team of seasoned experts, the company is dedicated to advancing the global cannabis industry by creating effective products, formulations and technology platforms that support and replenish the Endocannabinoid System. CBx Sciences holds distribution, licensing and intellectual property agreements with a number of leading cannabis and healthcare brands including Evolab. Learn more at CBxSciences.com.

Supporting Resources:
Follow @CBxSciences on:                            

 

SOURCE CBx Sciences


These press releases may also interest you

at 06:30
The "Sample Preparation Market by Product (Workstation, Instrument {Pipette, Washer, Centrifuge, Grinder}, Consumable {Kits, Filters, Plates}) Technique (Solid Phase Extraction, Purification) Application (Drug Discovery, Diagnostic) - Global Forecast...

at 06:15
The "Global Immune Health Supplements Market - Outlook & Forecast 2023-2028" report has been added to  ResearchAndMarkets.com's offering. The global immune health supplements market was valued at $20.80 billion in 2022 and is expected to reach...

at 06:08
ConTemporary Locums, a physician-focused medical staffing company, is ushering in a new era with a bold rebrand: Era Locums. This brand evolution marks a commitment to continued innovation and a deeper connection with the company's physician and...

at 06:05
AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to recognize March 25-31 as National Physicians Week. This week and throughout the year, we celebrate the dedication of physicians who selflessly...

at 06:00
The "Liquid Biopsy Markets by Cancer, Usage, Biomarker, Place, & Product With Price and Volume Outlook. Including Executive and Consultant Guides and Customized Forecasting and Analysis 2023-2027" report has been added to  ResearchAndMarkets.com's...

at 05:45
The "Global Proteomic Biomarker Analytics Market Forecasts by Application, Technology, Product, and Place, with Executive & Consultant Guides; Including Customized Forecasting and Analysis" report has been added to  ResearchAndMarkets.com's offering....



News published on and distributed by: